# FDA Inspection 1041525 - Gemini Pharmaceuticals, Inc. - February 16, 2018

Source: https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/5f815dde-5720-44ae-a6e5-ab350f64a85e
Source feed: FDA_Inspections

> FDA Inspection 1041525 for Gemini Pharmaceuticals, Inc. on February 16, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1041525
- Company Name: Gemini Pharmaceuticals, Inc.
- Inspection Date: 2018-02-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1175407 - 2022-07-26](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/92c472bb-08e5-409c-b8ae-8486b86edb42)
- [FDA Inspection 1175407 - 2022-07-26](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/e65a779b-d253-4945-bbc8-dfca238ee96d)
- [FDA Inspection 1064447 - 2018-08-23](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/75b14ea2-9725-4534-814a-36758a020bba)
- [FDA Inspection 936886 - 2015-06-30](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/6d577591-8391-4524-a2b4-21427df5636b)
- [FDA Inspection 856101 - 2013-11-08](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/755ecb80-8106-43f2-8f2c-49f8a092e6ac)

Company: https://www.keypedia.com/companies/gemini-pharmaceuticals-inc/9e83f65c-3863-4ad6-a434-b37d9673ac0f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c